Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

Blog

The America College of Cardiology has released its list of key late-breaking clinical trials at the ACC 2015 meeting in ...

Home January 21, 2015
Home
News

January 8, 2015 — Stentys announced that the Self-Apposing Stent has been implanted more than 10,000 times in patients ...

Home January 08, 2015
Home
News

January 5, 2015 — InspireMD, Inc. announced results from two important clinical trials. Thirty-day results from the ...

Home January 05, 2015
Home
bioresorbable stents
Feature | Dave Fornell
Ongoing clinical trials of bioresorbable stents continue to show positive data for the devices, which are widely ...
Home December 31, 2014
Home
News

December 31, 2014 — Reva Medical initiated patient enrollment with its Fantom bioresorbable drug-eluting scaffold. The ...

Home December 31, 2014
Home
News

December 30, 2014 — Wearable technologies, possible changes to stenting practices, state legislation on energy drinks ...

Home December 30, 2014
Home
News

December 22, 2014 — Veniti Inc. announced that it has enrolled the first United States patients in the Virtus trial of ...

Home December 22, 2014
Home
News

December 10, 2014 — In the first successful United States trial of a bioabsorbable polymer stent, the Boston Scientific ...

Home December 10, 2014
Home
News
November 25, 2014 — CeloNova BioSciences, Inc., announced that positive frst-in-man (FIM) clinical trial results found ...
Home November 25, 2014
Home
DAPT study
Feature
November 18, 2014 — Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary ...
Home November 18, 2014
Home
News

Nov. 14, 2014 — Micell Technologies Inc. announced commercialization plans for its MiStent Sirolimus Eluting Absorbable ...

Home November 14, 2014
Home
News

Nov. 13, 2014 — Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations ...

Home November 13, 2014
Home
News

November 11, 2014 — Five-year results from the largest and longest-running clinical trial of a drug-eluting stent for ...

Home November 11, 2014
Home
VIVA, VIVA Physicians, Peripheral, Carotid Artery Device, clinical trial results
Feature

Nov. 11, 2014 — Viva Physicians, a not-for-profit organization in the field of vascular medicine and intervention ...

Home November 11, 2014
Home
Technology

November 4, 2014 — The U.S. Food and Drug Administration (FDA) has cleared the Abbott family of Xience everolimus ...

Home November 04, 2014
Home
Subscribe Now